A study that looks into the potential of wearables to non-invasively measure blood glucose has come up with promising results ...

Nanowear, a leader in home-based cardiometabolic digital diagnostics announced that SimpleSensetm, a nanotechnology-enabled wearable, mobile and software diagnostics platform, will ingest glucose data ...

In a new study in the journal Diabetes Technology & Therapeutics (DTT), investigators evaluated the accuracy of the 15.5-day ...

will ingest glucose data from Dexcom G7 Continuous Glucose Monitoring Systems (CGM) time synchronously alongside Nanowear’s previously FDA cleared cardiovascular biomarkers. The continuous ...

Dexcom made a significant design change to a component used in its sensors and did not adequately validate the change, ...

Dexcom is preparing to launch a 15-day version of its G7 continuous glucose monitor, based on data ... measurement comparing CGM results to blood glucose readings. Dexcom has submitted an ...

CGMs are transforming health tracking for non-diabetics, providing insights into glucose levels and influencing dietary choices and athletic performance.

Dexcom’s investigational 15-day continuous glucose monitor has a lower mean absolute relative difference than the current ...

The general mood among these heavyweight investors is divided, with 12% leaning bullish and 50% bearish. Among these notable ...

DexCom has been a great trade. While the S&P 500 was flat, the stock price has climbed by 8% to $74.17 per share. This run-up ...